Plasma contact factors as therapeutic targets
Author:
Funder
National Institutes of Health
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference198 articles.
1. Dabigatran for the prevention and treatment of thromboembolic disorders;Enriquez;Expert Rev Cardiovasc Ther,2015
2. Overview of the new oral anticoagulants: opportunities and challenges;Yeh;Arterioscler Thromb Vasc Biol,2015
3. Pharmacologic therapies in anticoagulation;Ferreira;Med Clin North Am,2016
4. Evolving treatments for arterial and venous thrombosis: role of the direct oral anticoagulants;Chan;Circ Res,2016
5. Current challenges and future prospects in oral anticoagulant therapy;Czuprynska;Br J Haematol,2017
Cited by 50 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Factor XII contact activation can be prevented by targeting 2 unique patches in its epidermal growth factor-like 1 domain with a nanobody;Journal of Thrombosis and Haemostasis;2024-09
2. Plasma kallikrein supports FXII-independent thrombin generation in mouse whole blood;Blood Advances;2024-06-12
3. Design, Synthesis, and Evaluation of New Hybrid Derivatives of 5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-2(1H)-one as Potential Dual Inhibitors of Blood Coagulation Factors Xa and XIa;Molecules;2024-01-11
4. Inhibidores del factor XI: una nueva era en el tratamiento antitrombótico;Medicina Clínica;2024-01
5. Factor XI inhibitors: A new era in antithrombotic therapy;Medicina Clínica (English Edition);2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3